First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic.
Boo
T W
TW
Walsh
F
F
Crowley
B
B
D000150:Acinetobacter / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D000151:Acinetobacter Infections / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D007494:Ireland; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D013845:Thienamycins / Q000494:pharmacology; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism*
D013845:Thienamycins; D015378:Imipenem; C466679:beta-lactamase OXA-23; D001618:beta-Lactamases; D000077731:Meropenem